Abstract
Background: Growing evidence suggests that increasing opportunities for social engagement has the potential to support successful aging. However, many older adults may have limited access to in-person social engagement opportunities due to barriers such as transportation. We outline the development, design, methodology, and baseline characteristics of a randomized controlled trial that assessed the benefits of a social engagement intervention delivered through the OneClick video conferencing platform to older adults with varying levels of cognitive functioning. Methods: Community-dwelling older adults with and without cognitive challenges were randomly assigned to a social engagement intervention group or a waitlist control group. Participants were asked to attend twice-weekly social engagement events for 8 weeks via OneClick. Outcomes included social engagement and technology acceptance for both groups at baseline, week-4, and week-8 assessments. As an extension, the waitlist control group had an opportunity to participate in the intervention, with outcomes assessed at weeks 12 and 16. Results: We randomly assigned 99 participants (mean age = 74.1 ± 6.7, range: 60–99), with 50 in the immediate intervention group and 49 in the waitlist control group. About half of the participants reported living alone (53.5%), with a third (31%) falling into the cognitively impaired range on global cognitive screening. The groups did not differ at baseline on any of the outcome measures. Conclusions: Outcomes from this study will provide important information regarding the feasibility and efficacy of providing technology-based social engagement interventions to older adults with a range of cognitive abilities.
Original language | English (US) |
---|---|
Article number | 101308 |
Journal | Contemporary Clinical Trials Communications |
Volume | 39 |
DOIs | |
State | Published - Jun 2024 |
Keywords
- Cognitive impairment
- Older adults
- Randomized controlled trial
- Social engagement
- Technology
- Videoconferencing
ASJC Scopus subject areas
- Pharmacology